B2M mutation
|
Mantle Cell Lymphoma
|
B2M mutation
|
Mantle Cell Lymphoma
|
acalabrutinib Resistant: C3 – Early Trials
|
acalabrutinib Resistant: C3 – Early Trials
|
B2M mutation
|
HL
|
B2M mutation
|
HL
|
sintilimab Resistant: C3 – Early Trials
|
sintilimab Resistant: C3 – Early Trials
|
B2M mutation
|
Melanoma
|
B2M mutation
|
Melanoma
|
pembrolizumab Resistant: C4 – Case Studies
|
pembrolizumab Resistant: C4 – Case Studies
|